These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 2274676
1. Cholecystokinin is a regulator of intestinal phase-stimulated PP release. Adler G, Beglinger C, Braun U, Reinshagen M, Koop I, Schafmayer A. Regul Pept; 1990 Sep 10; 30(2):105-11. PubMed ID: 2274676 [Abstract] [Full Text] [Related]
2. Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans. Hildebrand P, Ensinck JW, Ketterer S, Delco F, Mossi S, Bangerter U, Beglinger C. J Clin Endocrinol Metab; 1991 May 10; 72(5):1123-9. PubMed ID: 2022712 [Abstract] [Full Text] [Related]
3. Effect of loxiglumide, a cholecystokinin antagonist, on pancreatic polypeptide release in humans. Meier R, Hildebrand P, Thumshirn M, Albrecht C, Studer B, Gyr K, Beglinger C. Gastroenterology; 1990 Dec 10; 99(6):1757-62. PubMed ID: 2227288 [Abstract] [Full Text] [Related]
4. Interaction of the cholinergic system and cholecystokinin in the regulation of endogenous and exogenous stimulation of pancreatic secretion in humans. Adler G, Beglinger C, Braun U, Reinshagen M, Koop I, Schafmayer A, Rovati L, Arnold R. Gastroenterology; 1991 Feb 10; 100(2):537-43. PubMed ID: 1702077 [Abstract] [Full Text] [Related]
5. Intestinal phase of human antro-pyloro-duodenal motility: cholinergic and CCK-mediated regulation. Katschinski M, Schirra J, Begliner C, Langbein S, Wank U, D'Amato M, Arnold R. Eur J Clin Invest; 1996 Jul 10; 26(7):574-83. PubMed ID: 8864420 [Abstract] [Full Text] [Related]
6. Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man. Gabryelewicz A, Kulesza E, Konturek SJ. Scand J Gastroenterol; 1990 Jul 10; 25(7):731-8. PubMed ID: 2396088 [Abstract] [Full Text] [Related]
7. Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide. Fried M, Erlacher U, Schwizer W, Löchner C, Koerfer J, Beglinger C, Jansen JB, Lamers CB, Harder F, Bischof-Delaloye A. Gastroenterology; 1991 Aug 10; 101(2):503-11. PubMed ID: 2065926 [Abstract] [Full Text] [Related]
8. Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man. Hildebrand P, Beglinger C, Gyr K, Jansen JB, Rovati LC, Zuercher M, Lamers CB, Setnikar I, Stalder GA. J Clin Invest; 1990 Mar 10; 85(3):640-6. PubMed ID: 2312719 [Abstract] [Full Text] [Related]
9. Role of cholecystokinin in bombesin- and meal-stimulated pancreatic polypeptide secretion in dogs. Jansen JB, de Jong AJ, Singer MV, Niebel W, Rovati LC, Lamers CB. Dig Dis Sci; 1990 Sep 10; 35(9):1073-7. PubMed ID: 2390922 [Abstract] [Full Text] [Related]
10. Effect of proglumide, a cholecystokinin receptor antagonist, on caerulein-stimulated pancreatic enzyme secretion and pancreatic polypeptide release in the dog. Fried M, Beglinger C, Koehler E, Whitehouse I, Varga L, Gyr K. Regul Pept; 1984 Mar 10; 8(2):117-22. PubMed ID: 6729149 [Abstract] [Full Text] [Related]
12. Cholecystokinin receptor antagonist loxiglumide modulates plasma levels of gastro-entero-pancreatic hormones in man. Feedback control of cholecystokinin and gastrin secretion. Schmidt WE, Creutzfeldt W, Höcker M, Nustede R, Choudhury AR, Schleser A, Rovati LC, Fölsch UR. Eur J Clin Invest; 1991 Oct 10; 21(5):501-11. PubMed ID: 1752290 [Abstract] [Full Text] [Related]
13. Physiological control of cholecystokinin release and pancreatic enzyme secretion by intraduodenal bile acids. Koop I, Schindler M, Bosshammer A, Scheibner J, Stange E, Koop H. Gut; 1996 Nov 10; 39(5):661-7. PubMed ID: 9026479 [Abstract] [Full Text] [Related]
14. Effects of CCK receptor blockade on intestinal motor activity in conscious dogs. Niederau C, Karaus M. Am J Physiol; 1991 Feb 10; 260(2 Pt 1):G315-24. PubMed ID: 1996649 [Abstract] [Full Text] [Related]
15. Gastrointestinal motor and secretory responses to cholinergic stimulation in humans. Differential modulation by muscarinic and cholecystokinin receptor blockade. Katschinski M, Steinicke C, Reinshagen M, Dahmen G, Beglinger C, Arnold R, Adler G. Eur J Clin Invest; 1995 Feb 10; 25(2):113-22. PubMed ID: 7737260 [Abstract] [Full Text] [Related]
16. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide. Schmidt WE, Creutzfeldt W, Schleser A, Choudhury AR, Nustede R, Höcker M, Nitsche R, Sostmann H, Rovati LC, Fölsch UR. Am J Physiol; 1991 Feb 10; 260(2 Pt 1):G197-206. PubMed ID: 1996640 [Abstract] [Full Text] [Related]
17. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori. Konturek JW. J Physiol Pharmacol; 1994 Dec 10; 45(4 Suppl 1):3-66. PubMed ID: 7787215 [Abstract] [Full Text] [Related]
18. Role of cholecystokinin in the control of gastric emptying and secretory response to a fatty meal in normal subjects and duodenal ulcer patients. Konturek JW, Thor P, Maczka M, Stoll R, Domschke W, Konturek SJ. Scand J Gastroenterol; 1994 Jul 10; 29(7):583-90. PubMed ID: 7939393 [Abstract] [Full Text] [Related]